Advair vs. Xopenex

See how Advair and Xopenex compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Advair is a twice-daily combination inhaler that controls asthma and COPD over time, while Xopenex is a short-acting bronchodilator used to relieve sudden breathing symptoms.

  • Advair combines an inhaled steroid with a long-acting bronchodilator and is not meant for fast relief, while Xopenex works quickly but does not treat airway inflammation.

  • Many patients use these drugs together, with Advair for daily control and Xopenex as a rescue inhaler when symptoms flare.

Advair vs. Xopenex Drug Summary

Advair

Advair is a combination corticosteroid and long-acting beta2-agonist (ICS/LABA) inhaler used for daily maintenance treatment of asthma in people 4 and older and for COPD. It is taken twice a day through a Diskus powder inhaler and is not intended for fast relief of a breathing attack.

Xopenex

Xopenex is a short-acting beta2-agonist bronchodilator used to treat or prevent sudden bronchospasm in asthma and other reversible airway diseases. It is delivered through a nebulizer solution or an HFA inhaler and works within minutes.

Advair vs. Xopenex Side Effects

Advair

Most common
Bronchitis/cough (up to 3%)
Upper respiratory infection (up to 3%)
Throat irritation (up to 3%)
Oral thrush (up to 3%)

Xopenex

Most common
Bronchitis (up to 2%)
Dizziness (up to 2%)
Pain (up to 2%)
Pharyngitis (up to 2%)

Advair vs. Xopenex Dosage

Advair

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mcg/50 mcg twice daily At the start
Maximum dose 500 mcg/50 mcg twice daily If needed
Dose changes 2 increases As tolerated

Xopenex

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.31 mg three times daily At the start
Maximum dose 90 mcg (2 inhalations) q4-6h If needed
Dose changes 4 increases As tolerated

Advair vs. Xopenex Indications

Advair

Advair is approved for the ongoing maintenance treatment of asthma in patients 4 years and older and for maintenance treatment of airflow obstruction caused by COPD, including chronic bronchitis and emphysema. It is also used to reduce the number of COPD exacerbations in people who have had them before. It is not meant to stop a breathing attack that is already happening.

  • Long-term asthma control in patients 4 and older

  • Maintenance treatment of COPD airflow obstruction

  • Reduces frequency of COPD exacerbations

  • Taken twice daily on a fixed schedule

Xopenex

Xopenex is approved for the treatment or prevention of bronchospasm in people with asthma or other reversible obstructive airway diseases. It is used as a rescue medication when breathing symptoms occur or before activities known to trigger them, such as exercise. It is not approved as a daily controller therapy for asthma or COPD.

  • Fast relief of acute asthma symptoms

  • Prevention of exercise-induced bronchospasm

  • Used with nebulizer or HFA inhaler

  • Often paired with a daily controller inhaler

Advair vs. Xopenex Pros and Cons

Advair

Advair addresses both the inflammation and the airway tightening involved in asthma and COPD, making it a mainstay of daily disease control. Because it is a combination product taken on a schedule, it works best alongside a separate rescue inhaler for sudden symptoms.

Pros

  • Treats both inflammation and bronchoconstriction in one inhaler

  • FDA-approved for both asthma and COPD maintenance

  • Available as a lower-cost generic (Wixela Inhub)

  • Reduces long-term risk of COPD exacerbations

Cons

  • Not effective for sudden breathing attacks

  • Requires correct twice-daily inhaler technique

  • Long-acting beta-agonist component carries an asthma safety history

  • Roughly $300 to $500 per month without insurance, higher than Xopenex

Xopenex

Xopenex offers quick relief when airways suddenly tighten, which makes it a common rescue partner to a controller like Advair. It does not treat the underlying inflammation that drives asthma or COPD, so it is not meant to replace daily maintenance therapy.

Pros

  • Works within minutes for acute symptom relief

  • Available as both nebulizer solution and HFA inhaler

  • Single-isomer formula intended to limit side effects seen with racemic albuterol

  • Roughly $55 to $120 per month without insurance, lower than Advair

Cons

  • Does not treat airway inflammation

  • May require dosing as often as every 4 hours

  • Overuse can raise heart rate and blood pressure

  • Not approved to reduce COPD exacerbations

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.